Change Country
Welcome to LuxembourgWelcome
Please read the important information below before continuing to our website

The Lyxor ETFs on this website may be restricted for certain individuals or in certain countries pursuant to the national regulations applicable to those individuals or countries. It is therefore your responsibility to ensure that you are authorised to invest in the Lyxor ETFs on this website. 


If you are an investor in the United Kingdom, please go to  

If you are an investor in the Netherlands, please go to  

If you are an investor in Italy, please go to  

If you are an investor in Spain, please go to  

If you are an investor in Austria, please go to  

If you are an investor in Germany, please go to   

If you are an investor in Singapore, please go to  

If you are an investor in Switzerland, please go to  

If you are an investor in Belgium, please go to  

If you are an investor in Poland, please go to 

If you are an investor in Norway, please go to

If you are an investor in Denmark, please go to

If you are an investor in Luxembourg, please go to

If you are an investor in Sweden, please go to

If you are an investor in Finland, please go to



The Lyxor ETFs on this website are undertakings for collective investment in transferable securities (UCITS) (i) domiciled in France and approved by the Autorité des Marchés Financiers (AMF) or, (ii) domiciled in Luxembourg, approved by the Commission de Surveillance du Secteur Financier (CSSF) and authorised to market their units or shares in the French Republic in accordance with the notification procedure under Article 93 of Directive 2009/65/EC. Investors should note that the prospectuses of certain Lyxor ETFs under Luxembourg law that have been notified in accordance with this procedure are only available on the website in English. A French translation of these prospectuses can be obtained upon request by sending a letter to Lyxor International Asset Management (“Lyxor”) – 17 Cours Valmy, 92987 Paris La Défense, France.


The information on this website is not intended for persons or entities that are resident, located or registered in jurisdictions that are not authorised to distribute Lyxor ETFs. As a result, the information on this website does not constitute an offer or solicitation to buy or sell units or shares in these ETFs by anyone in any jurisdiction:


(a)   in which such an offer or solicitation is unauthorised;

(b)   in which Lyxor is not qualified to make such an offer or solicitation; or 

(c)   in which it is unlawful to make such an offer or solicitation.


In particular, the Lyxor ETFs on this website are not and will not be registered under the United States Securities Act of 1933, as amended. As such, they may not be offered or sold within the United States of America, except in specific cases where transactions are exempt from registration under the Securities Act. The ETFs listed on this website may not be sold to US citizens or transferred to the United States by any other means, unless this transaction is not subject to any specific registration under US law. 


Any person from a jurisdiction to which the above-mentioned restrictions apply should inform themselves of and observe these restrictions.


This website is intended for commercial purposes and is not regulatory in nature. Although the information provided has been drawn up on the basis of sources considered to be reliable, there is no guarantee that it is accurate, complete or relevant. Some of the information on this website is provided on the basis of market data collected at a specific time and may therefore vary over time. Lyxor advises investors to read the risk factors section of the prospectus and the key investor information document carefully. These documents can be found on the website.


The net asset value (“NAV”) of Lyxor ETFs may at any time be subject to considerable price fluctuations, which in some cases may lead to the loss of all of the capital invested. Investors should note that some ETFs may be sensitive to fluctuations in the exchange rate between their reference currency and that of the underlying index, as well as of the components of the underlying index.


Before investing in a Lyxor ETF, you should carry out your own risk analysis of the product from a legal, tax and accounting perspective, rather than basing your decision solely on the information provided. If necessary, you should consult your own advisers or any other qualified professional. 


Subject to compliance with the legal obligations by which they are bound, Lyxor or any entity within the same group shall not be held liable for any financial or other consequences of an investment in the product. 



By clicking on institutional or individual above, I confirm that I have read and understood the information provided herein, and that I am resident or registered in Luxembourg.


15 May 2019

Is your Robo ETF keeping up with the times?​​

martin ford

The Robotics and AI megatrend is not a new story, but it is one that’s evolving continually. Is your portfolio keeping pace? We spoke to futurist and renowned author Martin Ford1 and our own Head of Innovation, François Millet, to get their views on why industry developments matter and how the Rise of the Robots index adapts to change.

Why does this megatrend matter?

Martin Ford: Put simply, advances in the areas of robotics, automation and artificial intelligence are the biggest things that will happen in the next 10 or 20 years and beyond. They will be a source of incredible economic and societal disruption.

Companies across industries are benefiting from these technologies and are becoming far more efficient as a result. We’re not just talking about the usual IT and Industrials suspects – the impact is apparent in many other areas. Think of the advances in drug discovery by pharmaceutical companies, the automation of trading in financial institutions or the online recommendation engines used by consumer brands – all are increasingly powered by AI. Amazon reportedly has 10,000 employees dedicated solely to their Alexa and Echo technology. The trend is increasingly permeating our daily lives.

The reality is that the companies who will succeed in their respective sectors are the ones leveraging AI. They also have a strong financial incentive to improve their bottom lines through automation and AI. The drivers of change are impossible to ignore, and it’s a unique and incredibly exciting long-term opportunity for investors.

Why buy “builders” and “beneficiaries”?

MF: US tech titans like Alphabet (Google’s parent company), Amazon, and Facebook, as well as Chinese ones like Tencent and Baidu have the dominant positions in the AI field. Alphabet arguably commands the greatest, most powerful concentration of capability and talent that exists. Amazon and Facebook are not too far behind.

These big players are unlikely to cede their ground any time soon, largely because they have both the scale and the expertise to acquire innovative AI startups – Alphabet’s acquisition of DeepMind is a high-profile example. They are prominent examples of “builders” – or indeed “acquirers” – of AI technology. But investing in just some of these big names leaves out a considerable part of the opportunity set. There are hundreds of companies using AI to improve their business models. They are the “beneficiaries”.

Take a health insurance company that owns lots and lots of data about its patients. If a builder like Google supplies AI technology in its cloud server to this beneficiary, the data doesn’t then belong to Google, it still belongs to the insurer. While they may be leveraging Google’s technology, they still own the value of their patients’ data, and they’ll create more value from how they use it.

It’s a mistake to look at AI and say it’s all just Google and Facebook and Tencent, because the value they create ultimately gets distributed to other companies and sectors. From innovation in fintech to drug discovery in biotech, AI is a utility - one which will ultimately scale across and disrupt every industry.

What should we know about the Rise of the Robots index? 

MF: When they designed the Rise of the Robots index, Societe Generale’s Thematic Research team had to address a few challenges. How do you define a universe of relevant stocks that capture the megatrend? How do you target both the builders and the beneficiaries? How do you create a liquid, investable index, and how do you make sure it keeps up with industry trends?

There are three key things to know about the Rise of the Robots index:

1 – It’s big picture investing

We don’t just look at robotics companies, or companies leveraging traditional automation – we search for AI innovators as well. Robotics is certainly a part of AI disruption; it basically amounts to putting the technology into a physical machine. But there is a distinction between the cutting edge of AI and machine learning, and what we see as traditional automation. Robotics clearly has a role to play, but it’s a small part of the bigger picture. AI is much more important to the overall trend. Indices and ETFs which focus too much on traditional robotics risk leaving a lot of value on the table.

2 – It thinks forward

We know the biggest names in AI are the likes of Google, Amazon and Tencent, but the value chain doesn’t end there. It’s important your portfolio tells the full story. AI technologies are transforming banks, media giants, online retailers and healthcare providers to name but a few. AI can and will disrupt companies across the board, so we think forward by including those “beneficiaries” investing for the future, as well as the actual AI “builders”.

3 – It’s designed by man and machine

Robotics, automation and AI technology are evolving at dizzying speed, so we knew we needed a bespoke industry classification to ensure our eligible stock universe kept up with the times. To begin with, we carry out big data analysis across publicly available reports, presentations and meeting transcripts for the terms “Artificial Intelligence” and/or “Robotics” to screen for relevant companies, but unlike most of the other available indices, we don’t stop there. We then do our own digging to ensure other relevant companies are included, often from less obvious sectors such as finance or retail. Relevant IPOs (like Spotify last year) are also considered. We also check for obsolescence or irrelevance - some companies may be acquired by bigger outfits which don’t quite fit our criteria. Others may have started lagging behind in terms of AI and/or robotics investment. This periodic human touch acts as a quality control and is vital to ensure the universe – and by extension, the index – is keeping up with the times.

robo ai

Can you say more about the updates that were made to the index for 2019?

MF: Our annual review of the universe of stocks that are eligible to be included in the index is critical because the field of artificial intelligence is progressing so rapidly and new players are emerging constantly.  Towards the end of 2018, the number of eligible stocks in the universe increased from 210 to 228.  Many of these new companies were listed for the first time. These included high-profile technology IPOs like Spotify and DropBox, but also the security company ADT, digital training company Pluralsight, and many others. Beyond IPOs, we also look for established companies that are demonstrating a strong focus on leveraging AI or robotics in their business models.  For example, we added the Chinese company iFlyTek, which has become as leader in facial recognition technology, and Ocado Group, a UK-based online retailer that has used the latest advances in robotics and automation to develop state-of-the-art distribution centers.

It’s important to note that adding a stock to our universe simply means it becomes eligible to be included in the index. The stocks included and their relative weights within the index are determined entirely systematically and rebalanced each quarter.  This strategy allows us to identify companies with strong potential in the AI/robotics space and add them to the universe early-on.  However, a stock will be selected to be part of the index only when the company generates results that merit inclusion.

Why use Lyxor’s Robotics and AI ETF to capture the theme?

François Millet: Embracing the AI and robotics revolution could help future-proof your portfolio. Our ETF gives you exposure to 150 companies – at least 50% more than other like for like products2 – harnessing the power of AI and robotics, whether for themselves or their customers. And because we want to invest in growing companies that have demonstrated the ability to deliver real results, we screen them based on R&D expenditure on net sales, return on invested capital, and 3-year sales growth. This helps us distinguish between the potential winners and losers.


1Martin Ford is a futurist and the author of three books: Architects of Intelligence: The truth about AI from the people building it (2018), Rise of the Robots: Technology and the Threat of a Jobless Future (2015) and The Lights in the Tunnel: Automation, Accelerating Technology and the Economy of the Future (2009). He is also the founder of a Silicon Valley-based software development firm. His 2017 TED Talk on the impact of AI and robotics on the economy and society has been viewed more than 2 million times. In his role as consultant to Societe Generale, the designer of the ‘Rise of the Robots’ index underlying Lyxor’s ETF, Ford advises on the universe of stocks eligible for index inclusion.
2By “like-for-like”, we refer to European UCITS ETFs that target companies in the fields of both AI and Robotics & Automation.
3Source: Lyxor International Asset Management. Data as at 03/05/2019.

This article is for informative purposes only, and should not be taken as investment advice. Lyxor ETF does not in any way endorse or promote the companies mentioned in this article. The opinions expressed by Martin Ford are his own, and do not necessarily reflect the views of Lyxor International Asset Management or Societe Generale. Capital at risk. Please read our Risk Warning below.

Risk Warning

​This document is for the exclusive use of investors acting on their own account and categorised either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets in Financial Instruments Directive 2014/65/EU. These products comply with the UCITS Directive (2009/65/EC). Société Générale and Lyxor International Asset Management (LIAM) recommend that investors read carefully the “investment risks” section of the product’s documentation (prospectus and KIID). The prospectus and KIID are available free of charge on, and upon request to

Except for the United-Kingdom, where this communication is issued in the UK by Lyxor Asset Management UK LLP, which is authorized and regulated by the Financial Conduct Authority in the UK under Registration Number 435658, this communication is issued by Lyxor International Asset Management (LIAM), a French management company authorized by the Autorité des marchés financiers and placed under the regulations of the UCITS (2014/91/EU) and AIFM (2011/61/EU) Directives. Société Générale is a French credit institution (bank) authorised by the Autorité de contrôle prudentiel et de résolution (the French Prudential Control Authority).

The products mentioned are the object of market-making contracts, the purpose of which is to ensure the liquidity of the products on the London Stock Exchange, assuming normal market conditions and normally functioning computer systems. Units of a specific UCITS ETF managed by an asset manager and purchased on the secondary market cannot usually be sold directly back to the asset manager itself. Investors must buy and sell units on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units and may receive less than the current net asset value when selling them. Updated composition of the product’s investment portfolio is available on In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the product, and might also be mentioned on the websites of the stock exchanges where the product is listed.

Prior to investing in the product, investors should seek independent financial, tax, accounting and legal advice. It is each investor’s responsibility to ascertain that it is authorised to subscribe, or invest into this product. This document is of a commercial nature and not of a regulatory nature. This material is of a commercial nature and not a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor Asset Management (together with its affiliates, Lyxor AM) or any of their respective subsidiaries to purchase or sell the product referred to herein.

Research disclaimer

Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see appendix at the end of this report for the analyst(s) certification(s), important disclosures and disclaimers. Alternatively, visit our global research disclosure website

Conflicts of interest

This research contains the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to (i) ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees.​

Connect with us on linkedin